Difference between revisions of "Yamashina T, et al. Cancer Res. (2014) cited as Ref 463 in DOI: 10.1038/s41392-020-0110-5 (Q9726)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: PubMed ID (P140): 24638980, #quickstatements; #temporary_batch_1590001671040)
(‎Created claim: Page(s) (P105): 2698-2709, #quickstatements; #temporary_batch_1590074839150)
 
(4 intermediate revisions by the same user not shown)
Property / Publication Date
 +
2014
Timestamp+2014-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2014 / rank
 +
Normal rank
Property / Published In Name String
 +
Cancer Res.
Property / Published In Name String: Cancer Res. / rank
 +
Normal rank
Property / Volume
 +
74
Property / Volume: 74 / rank
 +
Normal rank
Property / title
 +
Cancer stem-like cells derived from chemoresistant tumors have a unique capacity to prime tumorigenic myeloid cells (English)
Property / title: Cancer stem-like cells derived from chemoresistant tumors have a unique capacity to prime tumorigenic myeloid cells (English) / rank
 +
Normal rank
Property / Page(s)
 +
2698-2709
Property / Page(s): 2698-2709 / rank
 +
Normal rank

Latest revision as of 15:42, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Yamashina T, et al. Cancer Res. (2014) cited as Ref 463 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Yamashina T
    0 references
    0 references
    2014
    0 references
    Cancer Res.
    0 references
    74
    0 references
    Cancer stem-like cells derived from chemoresistant tumors have a unique capacity to prime tumorigenic myeloid cells (English)
    0 references
    2698-2709
    0 references